title: Comment on the case report "Limb deformity in a newborn. Is rifampicin just an innocent bystander?" by Kalayci et al.
authors.affiliation: Department of Pharmacology, Izmir Katip Celebi University School of Medicine, Izmir, Turkey. ecekirdekci@yahoo.com.
authors.forename: E
authors.initials: E
authors.lastname: Keskin-Arslan
authors.forename: S
authors.initials: S
authors.lastname: Acar
authors.forename: Y C
authors.initials: YC
authors.lastname: Kaplan
mesh_terms: D000995:Antitubercular Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D012293:Rifampin / Q000009:adverse effects*; D014376:Tuberculosis / Q000188:drug therapy*; D038062:Upper Extremity Deformities, Congenital / Q000139:chemically induced* / Q000175:diagnosis*
chemical_list: D000995:Antitubercular Agents; D012293:Rifampin